Beyond PSA: New Prostate Cancer Screening Explained
New research shows a multi-marker test detects 90% of aggressive prostate cancers vs. 74% for PSA alone. What men should know.
Beyond PSA: New Prostate Cancer Screening Explained Read More »
New research shows a multi-marker test detects 90% of aggressive prostate cancers vs. 74% for PSA alone. What men should know.
Beyond PSA: New Prostate Cancer Screening Explained Read More »
New research suggests GLP-1 drugs like Ozempic and Wegovy may lower the risk of several obesity-linked cancers. Here is what the science actually shows.
Can GLP-1 Weight Loss Drugs Lower Cancer Risk? Read More »
Karolinska study in Radiology finds AI can flag 1 in 5 breast cancers up to 6 years before diagnosis. What it means for early detection.
AI Mammography Spots Breast Cancer 6 Years Before Diagnosis Read More »
New research is tightening safe alcohol limits to as low as 7 drinks a week. Here’s what science shows about cancer risk, heart health, and longevity.
How Much Alcohol Is Safe? Why Limits Keep Dropping Read More »
New research links GLP-1 drugs like Ozempic and Wegovy to a 30% lower breast cancer risk in women with obesity. What the data shows.
GLP-1 Drugs May Cut Breast Cancer Risk by 30% Read More »
A personalized mRNA cancer vaccine paired with Keytruda cut melanoma recurrence and death risk by 49% over 5 years, new trial data shows.
mRNA Cancer Vaccine Cuts Melanoma Recurrence by 49% Read More »
New colorectal cancer screening options now include blood tests and at-home stool kits. See how they compare to colonoscopy and who they fit.
Colorectal Cancer Screening: Blood Test vs Colonoscopy Read More »
New research shows pre-surgery immunotherapy may dramatically reduce colon cancer recurrence in patients with a key tumor subtype.
Pre-Surgery Immunotherapy May Cut Colon Cancer Return Read More »